| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-12 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-10 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-10 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-10 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.31 | 6e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.22 | 6e-08 |